Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity.
about
PET/CT imaging of Mycobacterium tuberculosis infectionEvolution of M. bovis BCG Vaccine: Is Niacin Production Still a Valid Biomarker?Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient miceConstruction and phenotypic characterization of an auxotrophic mutant of Mycobacterium tuberculosis defective in L-arginine biosynthesisIdentification of nitric oxide synthase as a protective locus against tuberculosisPathogen proliferation governs the magnitude but compromises the function of CD8 T cellsDelayed expansion and contraction of CD8+ T cell response during infection with virulent Salmonella typhimurium.A reduced antigen load in vivo, rather than weak inflammation, causes a substantial delay in CD8+ T cell priming against Mycobacterium bovis (bacillus Calmette-Guérin).Regulation of mycobacterial growth by the hypothalamus-pituitary-adrenal axis: differential responses of Mycobacterium bovis BCG-resistant and -susceptible mice.Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages.Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions.An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis.Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis.Mycobacterium tuberculosis signal transduction system required for persistent infections.Reactivation of latent tuberculosis: variations on the Cornell murine modelCharacterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidatesExtensive Mycobacterium bovis BCG infection of liver parenchymal cells in immunocompromised mice.The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice.Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulatorThe nature and consequence of genetic variability within Mycobacterium tuberculosis.Does M. tuberculosis genomic diversity explain disease diversity?Nuclear imaging: a powerful novel approach for tuberculosis.Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis.Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis.Unique model of dormant infection for tuberculosis vaccine developmentDifferences in the growth of paired Ugandan isolates of Mycobacterium tuberculosis within human mononuclear phagocytes correlate with epidemiological evidence of strain virulence.Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice.Urease activity does not contribute dramatically to persistence of Mycobacterium bovis bacillus Calmette-GuérinUse of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulence.Bacillary replication and macrophage necrosis are determinants of neutrophil recruitment in tuberculosis.Complete annotated genome sequence of Mycobacterium tuberculosis Erdman.Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and CancerEpidemiologic consequences of microvariation in Mycobacterium tuberculosis.Effect of morphine on Mycobacterium smegmatis infection in mice and macrophagesEvidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis.Inhibition of Ca(2+) signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages.Effect of hydrocortisone succinate on growth of Chlamydia pneumoniae in vitro.A Mutation in the 16S rRNA Decoding Region Attenuates the Virulence of Mycobacterium tuberculosis.Inducible nitric oxide synthase: what difference does it make?Review of the prevalence and drug resistance of tuberculosis in prisons: a hidden epidemic.
P2860
Q26748493-45487FFC-9936-42DD-9635-EE76B8822A90Q28083050-AEEDB56D-CAB1-47E4-AF30-D0184A1EC214Q28486555-CC0BC78F-A6ED-4477-8161-49BBF8E29BD5Q28486881-71245DAD-CA38-4F8A-88A1-3A6F2CD4D29EQ29620411-A11251D9-3B07-4914-9250-CE1CE1F78313Q33590091-D419D76D-D4F7-4048-92DC-429CE67D21F1Q33590099-3881CD17-0032-4F4A-87FF-C7AEF41ED7D7Q33590110-9B7317AA-BD1A-451E-BCFA-59E30FBA20E6Q33614521-F52F5D98-DFD4-47E2-A494-B8D7D236AF1FQ33750649-30E27983-BE51-40BA-98C9-4DAA8A829C07Q33751770-111C3DA3-57C5-4A8E-971A-D026294E66C4Q33766722-614E6EAB-04D9-469A-B85E-4C93E0EBAABBQ33767388-C1CB8556-A8E8-465C-AF91-3113084A12A6Q33948032-DA1995F0-0BC4-4991-BE9F-35E851FEFB7FQ34001719-38C61393-6F8D-4A19-8A1D-B91FC35E93ADQ34006100-27EB2382-89FE-45DB-8518-68AAA3EEA545Q34007318-FDD765B6-F630-4AAE-BED6-64F8C2F9358CQ34009836-211E07E7-B7DA-40CC-9CA2-A76A58FC85BEQ34025554-0E7D8A43-AFB2-4708-B076-28ED1319BC23Q34174688-F122DD83-AE5D-4A4E-9ED8-30FBF3C66FA6Q34293557-1B0317B2-731E-4A8C-AAE3-EB343AC5ED0DQ34315731-8DB75047-3ACD-4FBC-AF9D-F8A4CFA71446Q34411806-EFBCC4A9-6E4F-4930-B7AB-159E9D34EFA3Q34737143-C30EB161-3407-4A15-A35B-94A97DC2AD94Q35023377-AD47F9C9-FCDE-4AAD-B3A4-04C42FED3AF2Q35220426-44B3938B-FEA9-49BB-9E3D-C9B66712E6D2Q35435985-01649BDE-D296-42C8-A4AA-DB112C2400DFQ35520963-61AC71E3-82D7-4D54-97F0-8B19459A1F7CQ35776668-0AA184CC-2FF6-4764-83D2-B7E3C8DF5304Q35868116-FAAEE262-0547-463F-AE61-82E3C6B96F98Q35943112-E1A8F85F-75EF-433E-9727-33F4217AD28EQ36127825-0018ECED-A4D1-449C-8DA2-8F57198B5E12Q36154214-46E0979F-997D-49DC-B307-7812F3719ADBQ36255672-56EEC9CC-6A11-42BA-97B8-09C7057897CBQ36365796-2964738C-801E-40B9-8A9F-6E4DED5C0F9FQ36375714-D8C0F415-2A9C-44DE-89E5-CDA11DDD45E6Q36539263-4770CBF6-C2A3-4B81-9AE7-644975E3DE6EQ37129868-3D778E48-F047-4708-9FA2-2C0A27D60D91Q37374566-1AB111AB-94AB-4B4E-B8D6-CBB278DD000BQ38265709-908FF209-1ED5-42DB-8A68-85995E114AB2
P2860
Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Mycobacterial virulence. Virul ...... absence of specific immunity.
@en
type
label
Mycobacterial virulence. Virul ...... absence of specific immunity.
@en
prefLabel
Mycobacterial virulence. Virul ...... absence of specific immunity.
@en
P2860
P356
P1476
Mycobacterial virulence. Virul ...... absence of specific immunity.
@en
P2093
P2860
P304
P356
10.1084/JEM.177.6.1723
P407
P577
1993-06-01T00:00:00Z